Discussion: TGF-β1 RNA interference in mouse primary dura cell culture: Downstream effects on TGF receptors, FGF-2, and FGF-R1 mRNA levels

Plastic and Reconstructive Surgery

Volumn 124, Issue 5, 2009, Pages 1474-1476

  Ko, Sae Hee ^a,b   Behr, Björn ^a,b   Longaker, Michael T ^a,b  

^a Stanford University ^*  (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MESSENGER RNA; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; CULTURE TECHNIQUE; CYTOLOGY; DOWN REGULATION; DRUG DELIVERY SYSTEM; DURA MATER; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; MOUSE STRAIN; NOTE; RNA INTERFERENCE;

ANIMALS; CELL CULTURE TECHNIQUES; CRANIAL SUTURES; CRANIOSYNOSTOSES; DOWN-REGULATION; DRUG DELIVERY SYSTEMS; DURA MATER; FIBROBLAST GROWTH FACTOR 2; MICE; MICE, INBRED STRAINS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 73549092167     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181b989de     Document Type: Note

References (22)

1. Lenton KA, Nacamuli RP, Wan DC, Helms JA, Longaker MT. Cranial suture biology. Curr Top Dev Biol. 2005;66: 287-328.
2. Sahar DE, Longaker MT, Quarto N. Sox9 neural crest determinant gene controls patterning and closure of the posterior frontal cranial suture. Dev Biol. 2005;280:344-361.
3. Slater BJ, Lenton KA, Kwan MD, Gupta DM, Wan DC, Longaker MT. Cranial sutures: A brief review. Plast Reconstr Surg. 2008;121:170e-178e.
4. Wan DC, Kwan MD, Lorenz HP, Longaker MT. Current treatment of craniosynostosis and future therapeutic directions. Front Oral Biol. 2008;12:209-230.
5. Levine JP, Bradley JP, Roth DA, McCarthy JG, Longaker MT. Studies in cranial suture biology: Regional dura mater determines overlying suture biology. Plast Reconstr Surg. 1998; 101:1441-1447.
6. Opperman LA, Sweeney TM, Redmon J, Persing JA, Ogle RC. Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev Dyn. 1993; 198:312-322.
7. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by doublestranded RNA in Caenorhabditis elegans. Nature 1998;391:806-811. (Pubitemid 28099681)
8. Fire AZ. Gene silencing by double-stranded RNA (Nobel Lecture). Angew Chem Int Ed Engl. 2007;46:6966-6984.
9. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschi T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411: 494-498.
10. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001;409:363-366.
11. Rand TA, Ginalski K, Grishin NV, Wang X. Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity. Proc Natl Acad Sci USA. 2004;101:14385-14389.
12. Ameres SL, Martinez J, Schroeder R. Molecular basis for target RNA recognition and cleavage by human RISC. Cell 2007;130:101-112.
13. Whitehead KA, Langer R, Anderson DG. Knocking down barriers: Advances in siRNA delivery. Nat Rev Drug Discov. 2009;8:129-138.
14. Gonzalez-Alegre P, Paulson HL. Technology insight: Therapeutic RNA interference. How far from the neurology clinic? Nat Clin Pract Neurol. 2007;3:394-404.
15. Grimm D. Small silencing RNAs: State-of-the-art. Adv Drug Deliv Rev. 2009;61:672-703.
16. Greenwald JA, Mehrara BJ, Spector JA, et al. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: Implications for suture fusion and patency. J Bone Miner Res. 2000;15:2413-2430.
17. Nacamuli RP, Fong KD, Lenton KA, et al. Expression and possible mechanisms of regulation of BMP3 in rat cranial sutures. Plast Reconstr Surg. 2005;116:1353-1362.
18. Poisson E, Sciote JJ, Koepsel R, Cooper GM, Opperman LA, Mooney MP. Transforming growth factor-beta isoform expression in the perisutural tissues of craniosynostotic rabbits. Cleft Palate Craniofac J. 2004;41:392-402.
19. Roth DA, Gold LI, Han VK, et al. Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion. Plast Reconstr Surg. 1997;99:300-309; discussion 310-316.
20. Mehrara BJ, Spector JA, Greenwald JA, Ueno H, Longaker MT. Adenovirus-mediated transmission of a dominant negative transforming growth factor-beta receptor inhibits in vitro mouse cranial suture fusion. Plast Reconstr Surg. 2002; 110:506-514.
21. Song HM, Fong KD, Nacamuli RP, et al. Mechanisms of murine cranial suture patency mediated by a dominant negative transforming growth factor-beta receptor adenovirus. Plast Reconstr Surg. 2004;113:1685-1697.
22. Mooney MP, Losken HW, Moursi AM, et al. Anti-TGF-beta2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits. Plast Reconstr Surg. 2007;119:1200- 1212; discussion 1213-1215.